Fairmount Funds Management LLC Amicus Therapeutics, Inc. Transaction History

Fairmount Funds Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $7.77 Million - $10.5 Million	-888,980 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $871,000 - $1.07 Million	100,000 Added 12.67%	888,980 $8.57 Million
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $4.84 Million - $12.6 Million	-526,415 Reduced 40.02%	788,980 $7.8 Million
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $1.89 Million - $3.48 Million	-140,000 Reduced 9.62%	1,315,395 $30.4 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $644,500 - $794,500	-50,000 Reduced 3.32%	1,455,395 $20.6 Million
Q2 2020 Aug 04, 2020	BUY	$8.86 - $15.69 $1.46 Million - $2.59 Million	165,000 Added 12.31%	1,505,395 $22.7 Million
Q1 2020 May 08, 2020	BUY	$6.63 - $11.16 $8.89 Million - $15 Million	1,340,395 New	1,340,395 $12.4 Million

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.